Diwakar Davar
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers 75
- CAR-T cell therapy research 55
- Cutaneous Melanoma Detection and Management 24
- Colorectal Cancer Treatments and Studies 9
- Immunology top 5%
- Immunotherapy and Immune Responses 37
-
- Melanoma and MAPK Pathways 23
- Gut microbiota and health 8
-
- Cancer Research and Treatments 10
- Co-authors
- John M. KirkwoodHassane M. ZarourAhmad A. TarhiniJason J. LukeCindy SanderLilit KarapetyanJan H. BeumerHussein Tawbi
- Journals
- Journal of Clinical Oncology (49 papers)SHILAP Revista de lepidopterología (10 papers)PLoS ONE (1 paper)
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
Diwakar Davar
124 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 86
- Oncology 1.1k
- Immunology 810
- Biological Psychiatry 23
- Molecular Biology 490
- Cancer Research 105
Countries citing papers authored by Diwakar Davar
This map shows the geographic impact of Diwakar Davar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diwakar Davar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diwakar Davar more than expected).
Fields of papers citing papers by Diwakar Davar
This network shows the impact of papers produced by Diwakar Davar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diwakar Davar. The network helps show where Diwakar Davar may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Diwakar Davar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 2 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 4 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 1 | |
| 10 | 2024 | 5 | |
| 11 | 2024 | 4 | |
| 12 | 2024 | 1 | |
| 13 | 2024 | 9 | |
| 14 | 2024 | 6 | |
| 15 | 2024 | 1 | |
| 16 | 2023 | 1 | |
| 17 | 2023 | 1 | |
| 18 | 2022 | 37 | |
| 19 | 2020 | 114 | |
| 20 | Toll-Like Receptor 9 Agonists in Cancer | 2020 | 2 |
About Diwakar Davar
Diwakar Davar is a scholar working on Oncology, Immunology and Biotechnology, having authored 134 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (75 papers), CAR-T cell therapy research (55 papers), Immunotherapy and Immune Responses (37 papers), Cutaneous Melanoma Detection and Management (24 papers), Melanoma and MAPK Pathways (23 papers), Cancer Research and Treatments (10 papers), Colorectal Cancer Treatments and Studies (9 papers) and Gut microbiota and health (8 papers). The work is most often cited by research in Oncology (1.1k citations), Immunology (810 citations) and Biological Psychiatry (23 citations). Diwakar Davar has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include John M. Kirkwood, Hassane M. Zarour, Ahmad A. Tarhini, Jason J. Luke, Cindy Sander, Lilit Karapetyan, Jan H. Beumer, Hussein Tawbi, Lana Hamieh and Hong Wang. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.